Extracellular Vesicles-Based Liquid Biopsy Market Size, Share, and Trends 2025 to 2034

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology 

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Extracellular Vesicles-Based Liquid Biopsy Market 

5.1. COVID-19 Landscape: Extracellular Vesicles-Based Liquid Biopsy Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porters Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Extracellular Vesicles-Based Liquid Biopsy Market, By Type of Vesicle

8.1. Extracellular Vesicles-Based Liquid Biopsy Market, by Type of Vesicle

8.1.1. Exosomes

8.1.1.1. Market Revenue and Forecast

8.1.2. Microvesicles

8.1.2.1. Market Revenue and Forecast

8.1.3. Apoptotic Bodies

8.1.3.1. Market Revenue and Forecast

Chapter 9. Global Extracellular Vesicles-Based Liquid Biopsy Market, By Component

9.1. Extracellular Vesicles-Based Liquid Biopsy Market, by Component

9.1.1. Kits & Reagents

9.1.1.1. Market Revenue and Forecast

9.1.2. Instruments

9.1.2.1. Market Revenue and Forecast

9.1.3. Services

9.1.3.1. Market Revenue and Forecast

Chapter 10. Global Extracellular Vesicles-Based Liquid Biopsy Market, By Application 

10.1. Extracellular Vesicles-Based Liquid Biopsy Market, by Application

10.1.1. Oncology

10.1.1.1. Market Revenue and Forecast

10.1.2. Neurology

10.1.2.1. Market Revenue and Forecast

10.1.3. Cardiovascular Diseases

10.1.3.1. Market Revenue and Forecast

10.1.4. Infectious Diseases

10.1.4.1. Market Revenue and Forecast

10.1.5. Others (Metabolic, Autoimmune)

10.1.5.1. Market Revenue and Forecast

Chapter 11. Global Extracellular Vesicles-Based Liquid Biopsy Market, By Biomarker Type

11.1. Extracellular Vesicles-Based Liquid Biopsy Market, by Biomarker Type

11.1.1. RNA Biomarkers

11.1.1.1. Market Revenue and Forecast

11.1.2. Protein Biomarkers

11.1.2.1. Market Revenue and Forecast

11.1.3. DNA Biomarkers

11.1.3.1. Market Revenue and Forecast

11.1.4. Lipid Biomarkers

11.1.4.1. Market Revenue and Forecast

Chapter 12. Global Extracellular Vesicles-Based Liquid Biopsy Market, By End User

12.1. Extracellular Vesicles-Based Liquid Biopsy Market, by End User

12.1.1. Academic & Research Institutes

12.1.1.1. Market Revenue and Forecast

12.1.2. Hospitals & Diagnostic Centers

12.1.2.1. Market Revenue and Forecast

12.1.3. Biotechnology & Pharmaceutical Companies

12.1.3.1. Market Revenue and Forecast

12.1.4. CROs & Laboratories

12.1.4.1. Market Revenue and Forecast

Chapter 13. Global Extracellular Vesicles-Based Liquid Biopsy Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Forecast, by Type of Vesicle

13.1.2. Market Revenue and Forecast, by Component

13.1.3. Market Revenue and Forecast, by Application

13.1.4. Market Revenue and Forecast, by Biomarker Type

13.1.5. Market Revenue and Forecast, by End User

13.1.6. U.S.

13.1.6.1. Market Revenue and Forecast, by Type of Vesicle

13.1.6.2. Market Revenue and Forecast, by Component

13.1.6.3. Market Revenue and Forecast, by Application

13.1.6.4. Market Revenue and Forecast, by Biomarker Type

13.1.6.5. Market Revenue and Forecast, by End User  

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Forecast, by Type of Vesicle

13.1.7.2. Market Revenue and Forecast, by Component

13.1.7.3. Market Revenue and Forecast, by Application

13.1.7.4. Market Revenue and Forecast, by Biomarker Type

13.1.7.5. Market Revenue and Forecast, by End User

13.2. Europe

13.2.1. Market Revenue and Forecast, by Type of Vesicle

13.2.2. Market Revenue and Forecast, by Component

13.2.3. Market Revenue and Forecast, by Application

13.2.4. Market Revenue and Forecast, by Biomarker Type  

13.2.5. Market Revenue and Forecast, by End User  

13.2.6. UK

13.2.6.1. Market Revenue and Forecast, by Type of Vesicle

13.2.6.2. Market Revenue and Forecast, by Component

13.2.6.3. Market Revenue and Forecast, by Application

13.2.7. Market Revenue and Forecast, by Biomarker Type  

13.2.8. Market Revenue and Forecast, by End User  

13.2.9. Germany

13.2.9.1. Market Revenue and Forecast, by Type of Vesicle

13.2.9.2. Market Revenue and Forecast, by Component

13.2.9.3. Market Revenue and Forecast, by Application

13.2.10. Market Revenue and Forecast, by Biomarker Type

13.2.11. Market Revenue and Forecast, by End User

13.2.12. France

13.2.12.1. Market Revenue and Forecast, by Type of Vesicle

13.2.12.2. Market Revenue and Forecast, by Component

13.2.12.3. Market Revenue and Forecast, by Application

13.2.12.4. Market Revenue and Forecast, by Biomarker Type

13.2.13. Market Revenue and Forecast, by End User

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Forecast, by Type of Vesicle

13.2.14.2. Market Revenue and Forecast, by Component

13.2.14.3. Market Revenue and Forecast, by Application

13.2.14.4. Market Revenue and Forecast, by Biomarker Type

13.2.15. Market Revenue and Forecast, by End User

13.3. APAC

13.3.1. Market Revenue and Forecast, by Type of Vesicle

13.3.2. Market Revenue and Forecast, by Component

13.3.3. Market Revenue and Forecast, by Application

13.3.4. Market Revenue and Forecast, by Biomarker Type

13.3.5. Market Revenue and Forecast, by End User

13.3.6. India

13.3.6.1. Market Revenue and Forecast, by Type of Vesicle

13.3.6.2. Market Revenue and Forecast, by Component

13.3.6.3. Market Revenue and Forecast, by Application

13.3.6.4. Market Revenue and Forecast, by Biomarker Type

13.3.7. Market Revenue and Forecast, by End User

13.3.8. China

13.3.8.1. Market Revenue and Forecast, by Type of Vesicle

13.3.8.2. Market Revenue and Forecast, by Component

13.3.8.3. Market Revenue and Forecast, by Application

13.3.8.4. Market Revenue and Forecast, by Biomarker Type

13.3.9. Market Revenue and Forecast, by End User

13.3.10. Japan

13.3.10.1. Market Revenue and Forecast, by Type of Vesicle

13.3.10.2. Market Revenue and Forecast, by Component

13.3.10.3. Market Revenue and Forecast, by Application

13.3.10.4. Market Revenue and Forecast, by Biomarker Type

13.3.10.5. Market Revenue and Forecast, by End User

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Forecast, by Type of Vesicle

13.3.11.2. Market Revenue and Forecast, by Component

13.3.11.3. Market Revenue and Forecast, by Application

13.3.11.4. Market Revenue and Forecast, by Biomarker Type

13.3.11.5. Market Revenue and Forecast, by End User

13.4. MEA

13.4.1. Market Revenue and Forecast, by Type of Vesicle

13.4.2. Market Revenue and Forecast, by Component

13.4.3. Market Revenue and Forecast, by Application

13.4.4. Market Revenue and Forecast, by Biomarker Type

13.4.5. Market Revenue and Forecast, by End User

13.4.6. GCC

13.4.6.1. Market Revenue and Forecast, by Type of Vesicle

13.4.6.2. Market Revenue and Forecast, by Component

13.4.6.3. Market Revenue and Forecast, by Application

13.4.6.4. Market Revenue and Forecast, by Biomarker Type

13.4.7. Market Revenue and Forecast, by End User

13.4.8. North Africa

13.4.8.1. Market Revenue and Forecast, by Type of Vesicle

13.4.8.2. Market Revenue and Forecast, by Component

13.4.8.3. Market Revenue and Forecast, by Application

13.4.8.4. Market Revenue and Forecast, by Biomarker Type

13.4.9. Market Revenue and Forecast, by End User

13.4.10. South Africa

13.4.10.1. Market Revenue and Forecast, by Type of Vesicle

13.4.10.2. Market Revenue and Forecast, by Component

13.4.10.3. Market Revenue and Forecast, by Application

13.4.10.4. Market Revenue and Forecast, by Biomarker Type

13.4.10.5. Market Revenue and Forecast, by End User

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Forecast, by Type of Vesicle

13.4.11.2. Market Revenue and Forecast, by Component

13.4.11.3. Market Revenue and Forecast, by Application

13.4.11.4. Market Revenue and Forecast, by Biomarker Type

13.4.11.5. Market Revenue and Forecast, by End User

13.5. Latin America

13.5.1. Market Revenue and Forecast, by Type of Vesicle

13.5.2. Market Revenue and Forecast, by Component

13.5.3. Market Revenue and Forecast, by Application

13.5.4. Market Revenue and Forecast, by Biomarker Type

13.5.5. Market Revenue and Forecast, by End User

13.5.6. Brazil

13.5.6.1. Market Revenue and Forecast, by Type of Vesicle

13.5.6.2. Market Revenue and Forecast, by Component

13.5.6.3. Market Revenue and Forecast, by Application

13.5.6.4. Market Revenue and Forecast, by Biomarker Type

13.5.7. Market Revenue and Forecast, by End User

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Forecast, by Type of Vesicle

13.5.8.2. Market Revenue and Forecast, by Component

13.5.8.3. Market Revenue and Forecast, by Application

13.5.8.4. Market Revenue and Forecast, by Biomarker Type

13.5.8.5. Market Revenue and Forecast, by End User

Chapter 14. Company Profiles

14.1. Bio-Techne Corporation

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Illumina

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. NanoView Biosciences

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Norgen Biotek Corp

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. System Biosciences

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Beckman Coulter

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. Hitachi Chemical Diagnostics

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. Exosome Diagnostics

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. HansaBioMed Life Sciences

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. Evox Therapeutics Ltd

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms